2021 RESEARCH
- Archives -Limiting screen time for young adults after concussion results in shorter duration of symptoms
Newly published research by Theodore E. Macnow, MD, shows that young adults who limited screen time for 48 hours immediately after suffering a concussion had a significantly shorter duration of symptoms than those who were permitted screen time.
Behind the research: Jae-Hyuck Shim strives to unlock cure for devastating childhood bone disease
Jae-Hyuck Shim, PhD, is inspired to develop a gene therapy for fibrodysplasia ossificans progressiva (FOP) after seeing the strength of families who have a child with the rare, crippling disease.
COVID-19 vaccine benefits pregnant women and babies, UMMS faculty say
The benefits of the COVID-19 vaccine for pregnant women and their babies are backed by solid, ongoing research, according to UMass Medical School faculty.
Helmsley Charitable Trust grant to fund UMMS IBD diet research
With the funding, Ana Maldonado-Contreras, PhD, will tailor a novel diet created at UMass Medical School to patients in Puerto Rico with different food availability and preferences.
Communicating science: Institute for Drug Resistance video series elevates awareness, understanding
In a new video series, UMass Medical School scientists explain their research to address the global health challenge of drug resistance. In the first video of the series, Medicines Designed to Last, Celia Schiffer, PhD, sets the stage with a straightforward overview of drug resistance.
Two new studies from Daryl Bosco lab shed new light on ALS mechanisms
Two studies from the lab of Daryl Bosco, PhD, offer new insights into the biochemical and molecular mechanisms that cause amyotrophic lateral sclerosis.
UMMS researchers take at-home COVID-19 testing to the streets in community enrollment events
Several times a week, UMass Medical School researchers offer Worcester-area residents the opportunity to enroll in some of the studies conducted for COVID-19 Test Us.
No Lyme vaccine yet, but antibody shot could provide seasonal immunity
Mark Klempner, MD, provides an update to a piece originally published last year on The Conversation about a yearly antibody for Lyme disease that shows promise for preventing infection.
COVID vaccine trial for kids on track, says KidCOVE principal investigator at UMMS
Moderna’s TeenCOVE and KidCOVE mRNA COVID-19 vaccine clinical trials are on track to expand the number of children in the Moderna KidCOVE trial, as requested this week by the Food and Drug Administration.
Guangping Gao and Dan Wang partner with ASC Therapeutics to develop novel gene therapy for maple syrup urine disease
UMass Medical School researchers Guangping Gao, PhD, and Dan Wang, PhD, are working with ASC Therapeutics to bring a gene therapy for maple syrup urine disease (MSUD) to the clinic.